Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Anti-HIV activity of a novel aminoglycoside-arginine conjugate.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.
Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo.
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.
Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation.
CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro.
Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.